Učitavanje...
Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
Ovarian cancer is the 5th most common cancer in UK women with a high relapse rate. The overall survival for ovarian cancer has remained low for decades prompting a real need for new therapies. Recurrent ovarian cancer remains confined in the peritoneal cavity in >80% of the patients, providing an...
Spremljeno u:
| Izdano u: | Porto Biomed J |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6726300/ https://ncbi.nlm.nih.gov/pubmed/31595233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbj.0000000000000007 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|